Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5205860
Max Phase: Preclinical
Molecular Formula: C33H41N5O7S
Molecular Weight: 651.79
Associated Items:
ID: ALA5205860
Max Phase: Preclinical
Molecular Formula: C33H41N5O7S
Molecular Weight: 651.79
Associated Items:
Canonical SMILES: COc1ccc(-c2cccc(S(=O)(=O)N[C@@H](Cc3cccc(C(=N)N)c3)C(=O)N3CCN(C(=O)OC(C)(C)C)CC3)c2)c(OC)c1
Standard InChI: InChI=1S/C33H41N5O7S/c1-33(2,3)45-32(40)38-16-14-37(15-17-38)31(39)28(19-22-8-6-10-24(18-22)30(34)35)36-46(41,42)26-11-7-9-23(20-26)27-13-12-25(43-4)21-29(27)44-5/h6-13,18,20-21,28,36H,14-17,19H2,1-5H3,(H3,34,35)/t28-/m0/s1
Standard InChI Key: TWVAPIQWRDSZTL-NDEPHWFRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 651.79 | Molecular Weight (Monoisotopic): 651.2727 | AlogP: 3.62 | #Rotatable Bonds: 10 |
Polar Surface Area: 164.35 | Molecular Species: BASE | HBA: 8 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.02 | CX Basic pKa: 11.47 | CX LogP: 2.77 | CX LogD: 0.86 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.22 | Np Likeness Score: -0.90 |
1. Pilgram O, Keils A, Benary GE, Müller J, Merkl S, Ngaha S, Huber S, Chevillard F, Harbig A, Magdolen V, Heine A, Böttcher-Friebertshäuser E, Steinmetzer T.. (2022) Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitors., 238 [PMID:35635944] [10.1016/j.ejmech.2022.114437] |
Source(1):